n,n-dimethyltryptamine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Sessa, B | 1 |
Biello, D | 1 |
Carbonaro, T; Forster, MJ; Gatch, MB; Rutledge, MA | 1 |
Martins, SS; Ompad, DC; Palamar, JJ; Su, MK | 1 |
Tullis, P | 1 |
5 other study(ies) available for n,n-dimethyltryptamine and n-methyl-3,4-methylenedioxyamphetamine
Article | Year |
---|---|
Can psychedelics have a role in psychiatry once again?
Topics: Hallucinogens; History, 20th Century; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Psychiatry; Psychoses, Substance-Induced | 2005 |
Not imagining it. Research into hallucinogens cautiously resumes.
Topics: Controlled Clinical Trials as Topic; Double-Blind Method; Hallucinogens; Humans; Mysticism; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Psilocybin; Research; Spirituality | 2006 |
Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in rats.
Topics: Animals; Behavior, Animal; Central Nervous System Stimulants; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Lysergic Acid Diethylamide; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Rats; Rats, Sprague-Dawley | 2009 |
Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Topics: Adolescent; Adult; Alkaloids; Cannabinoids; Cocaine; Female; Hallucinogens; Humans; Illicit Drugs; Logistic Models; Male; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Phenethylamines; Prevalence; Psychotropic Drugs; Self Report; Substance-Related Disorders; Surveys and Questionnaires; Tryptamines; Young Adult | 2015 |
How ecstasy and psilocybin are shaking up psychiatry.
Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resistant; Drug Prescriptions; Efficiency; Humans; Lysergic Acid Diethylamide; N-Methyl-3,4-methylenedioxyamphetamine; N,N-Dimethyltryptamine; Neuronal Plasticity; Niacin; Psilocybin; Psychiatry; Psychotherapy; Rumination, Cognitive; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic | 2021 |